Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Acadia Realty Trust (AKR)

Real Estate Investment Trusts

https://www.acadiarealty.com

Acadia Realty Trust is a real estate investment trust which specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company's portfolios are located primarily in metropolitan areas of the United States. The company operates through three segments: core portfolio, which consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon and generates the majority of total revenue; funds, which comprises the funds launched by the trust; and structured financing, which consists of notes receivable and related interest income.

411 THEODORE FREMD AVENUE, SUITE 300
RYE, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/27/1993

Market Cap

2,246,710,230

Shares Outstanding

101,380,000

Weighted SO

102,274,676

Total Employees

N/A

Upcoming Earnings

07/30/2024

Beta

1.4850

Last Div

0.7600

Range

13.24-22.51

Chg

-0.2800

Avg Vol

896153

Mkt Cap

2246710230

Exch

NYSE

Country

US

Phone

914-288-8100

DCF Diff

21.2008

DCF

0.4092

Div Yield

0.0338

P/S

6.2319

EV Multiple

25.9919

P/FV

1.2403

Div Yield %

3.3755

P/E

-163.5909

PEG

-35.4096

Payout

-5.1861

Current Ratio

3.1877

Quick Ratio

2.1110

Cash Ratio

0.5823

DSO

218.4897

DIO

170.6620

Op Cycle

389.1518

DPO

104.2694

CCC

284.8823

Gross Margin

0.3961

Op Margin

0.1791

Pretax Margin

-0.0876

Net Margin

-0.0375

Eff Tax Rate

-0.0088

ROA

-0.0032

ROE

-0.0079

ROCE

0.0155

NI/EBT

0.4277

EBT/EBIT

-0.4892

EBIT/Rev

0.1791

Debt Ratio

0.3994

D/E

0.9531

LT Debt/Cap

0.4540

Total Debt/Cap

0.4880

Int Coverage

-993.1231

CF/Debt

0.0754

Equity Multi

2.3863

Rec Turnover

1.6706

Pay Turnover

3.5005

Inv Turnover

2.1387

FA Turnover

12.9926

Asset Turnover

0.0848

OCF/Share

1.2354

FCF/Share

0.4117

Cash/Share

0.9208

OCF/Sales

0.3550

FCF/OCF

0.3333

CF Coverage

0.0754

ST Coverage

0.5907

CapEx Coverage

1.4999

Div&CapEx Cov

0.8237

P/BV

1.2403

P/B

1.2403

P/S

6.2319

P/E

-163.5909

P/FCF

52.6729

P/OCF

17.2663

P/CF

17.2663

PEG

-35.4096

P/S

6.2319

EV Multiple

25.9919

P/FV

1.2403

DPS

0.7200

Latest Headlines (EST)

GlobeNewswire Inc. May 10, 16:28 Akero Therapeutics präsentiert auf dem EASL-Kongress 2025 die Ergebnisse nach 96 Wochen der klinischen Phase-IIb-Studie SYMMETRY zu Efruxifermin bei Patienten mit kompensierter Zirrhose, die durch MASH verursacht wird, und zeigt eine Verbesserung der Fibr GlobeNewswire Inc. May 10, 16:28 Akero Therapeutics présente les résultats de la 96e semaine de l’essai clinique de phase 2b SYMMETRY sur l’éfruxifermine chez des patients atteints de cirrhose compensée causée par une stéatohépatite associée à un dysfonctionnement métabolique (MASH), mon GlobeNewswire Inc. May 10, 14:28 Akero Therapeutics gibt Publikation von „Phase IIb SYMMETRY“-Studie im New England Journal of Medicine bekannt GlobeNewswire Inc. May 10, 14:28 Akero Therapeutics annonce la publication de l’essai de phase 2b SYMMETRY dans le New England Journal of Medicine GlobeNewswire Inc. May 10, 14:00 Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025 Benzinga May 08, 05:28 Aker Horizons ASA: First-quarter results 2025 Benzinga May 07, 04:47 Aker BP reports first quarter 2025 results GlobeNewswire Inc. Apr 07, 21:59 INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Akero Therapeutics, Inc. to Contact Law Firm Benzinga Feb 12, 05:18 Fourth Quarter 2024 Results and Strategy Update The Motley Fool Feb 02, 23:21 This Stock Just Doubled in 1 Day -- Is It Still a Buy? GlobeNewswire Inc. Jan 29, 02:30 Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Benzinga Oct 14, 05:20 Aker BP: Third quarter 2024 trading update Investing.com Jul 19, 02:21 Akero Therapeutics CFO sells over $976k in company stock - Investing.com GlobeNewswire Inc. Jan 16, 01:55 The construction of a new 480 m2 building nearby Akropolis Vilnius starts GlobeNewswire Inc. Jan 16, 01:55 Pradedamos naujo 480 kv. metrų pastato Å¡alia Vilniaus „Akropolio“ statybos GlobeNewswire Inc. Jan 16, 01:55 The construction of a new 480 m2 building nearby Akropolis Vilnius starts GlobeNewswire Inc. Jan 16, 01:55 Pradedamos naujo 480 kv. metrų pastato Å¡alia Vilniaus „Akropolio“ statybos GlobeNewswire Inc. Jan 16, 01:55 The construction of a new 480 m2 building nearby Akropolis Vilnius starts GlobeNewswire Inc. Jan 16, 01:55 Pradedamos naujo 480 kv. metrų pastato Å¡alia Vilniaus „Akropolio“ statybos GlobeNewswire Inc. Jan 16, 01:55 The construction of a new 480 m2 building nearby Akropolis Vilnius starts

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.18 06/28/2024 05/01/2024 06/28/2024 07/15/2024
0.18 03/27/2024 02/28/2024 03/28/2024 04/15/2024
0.18 12/28/2023 11/02/2023 12/29/2023 01/12/2024
0.18 09/28/2023 08/09/2023 09/29/2023 10/13/2023
0.18 06/29/2023 05/03/2023 06/30/2023 07/14/2023
0.18 03/30/2023 01/17/2023 03/31/2023 04/14/2023
0.18 12/29/2022 11/09/2022 12/30/2022 01/13/2023
0.18 09/29/2022 08/10/2022 09/30/2022 10/14/2022
0.18 06/29/2022 05/04/2022 06/30/2022 07/15/2022
0.18 03/30/2022 02/15/2022 03/31/2022 04/14/2022
0.15 12/30/2021 11/03/2021 12/31/2021 01/14/2022
0.15 09/29/2021 08/10/2021 09/30/2021 10/15/2021
0.15 06/29/2021 05/05/2021 06/30/2021 07/15/2021
0.15 03/30/2021 02/10/2021 03/31/2021 04/15/2021
0.29 03/30/2020 02/27/2020 03/31/2020 04/15/2020
0.29 12/30/2019 11/05/2019 12/31/2019 01/15/2020
0.28 09/27/2019 08/13/2019 09/30/2019 10/15/2019
0.28 06/27/2019 05/09/2019 06/28/2019 07/15/2019
0.28 03/28/2019 02/28/2019 03/29/2019 04/15/2019
0.28 12/28/2018 11/15/2018 12/31/2018 01/15/2019
0.27 09/27/2018 08/07/2018 09/28/2018 10/15/2018
0.27 06/28/2018 05/11/2018 06/29/2018 07/13/2018
0.27 03/28/2018 02/27/2018 03/30/2018 04/13/2018
0.27 12/28/2017 11/06/2017 12/29/2017 01/12/2018
0.26 09/28/2017 08/10/2017 09/29/2017 10/13/2017
0.26 06/28/2017 05/24/2017 06/30/2017 07/14/2017
0.26 03/29/2017 03/16/2017 03/31/2017 04/14/2017
0.41 12/28/2016 11/10/2016 12/30/2016 01/13/2017
0.25 09/28/2016 08/11/2016 09/30/2016 10/14/2016
0.25 06/28/2016 05/10/2016 06/30/2016 07/15/2016
0.25 03/29/2016 03/18/2016 03/31/2016 04/15/2016
0.50 12/29/2015 11/16/2015 12/31/2015 01/15/2016
0.24 09/28/2015 08/13/2015 09/30/2015 10/15/2015
0.24 06/26/2015 05/27/2015 06/30/2015 07/15/2015
0.24 03/27/2015 03/10/2015 03/31/2015 04/15/2015
0.54 12/29/2014 12/05/2014 12/31/2014 01/15/2015
2.30 09/26/2014 08/06/2014 09/30/2014 10/15/2014
2.30 06/26/2014 05/14/2014 06/30/2014 07/15/2014
2.30 03/27/2014 03/11/2014 03/31/2014 04/15/2014
2.30 12/27/2013 11/05/2013 12/31/2013 01/15/2014
327.60 09/26/2013 08/06/2013 09/30/2013 10/15/2013
327.60 06/26/2013 05/16/2013 06/28/2013 07/15/2013
308.33 03/26/2013 02/26/2013 03/29/2013 04/15/2013
264.28 12/27/2012 12/26/2012 12/31/2012 01/15/2013
528.56 09/26/2012 08/15/2012 09/28/2012 10/15/2012
528.56 06/27/2012 06/07/2012 06/29/2012 07/13/2012
528.56 03/29/2012 03/23/2012 04/02/2012 04/13/2012
528.56 12/28/2011 12/19/2011 12/30/2011 02/01/2012
528.56 09/28/2011 08/11/2011 09/30/2011 10/17/2011
528.56 06/28/2011 06/22/2011 06/30/2011 07/15/2011
528.56 03/29/2011 03/21/2011 03/31/2011 04/15/2011
528.56 12/29/2010 12/03/2010 12/31/2010 02/01/2011
528.56 09/28/2010 08/27/2010 09/30/2010 10/15/2010
13.21K 06/28/2010 05/12/2010 06/30/2010 07/15/2010
13.21K 03/29/2010 03/05/2010 03/31/2010 04/15/2010
13.21K 12/29/2009 12/22/2009 12/31/2009 02/01/2010
13.21K 09/28/2009 09/16/2009 09/30/2009 10/15/2009
13.21K 06/26/2009 05/18/2009 06/30/2009 07/15/2009
15.42K 03/27/2009 03/09/2009 03/31/2009 04/15/2009
55.79K 12/29/2008 12/09/2008 12/31/2008 01/15/2009
15.42K 09/26/2008 08/15/2008 09/30/2008 10/15/2008
15.42K 06/26/2008 06/09/2008 06/30/2008 07/15/2008
15.42K 03/27/2008 03/19/2008 03/31/2008 04/15/2008
31.79K 12/27/2007 12/06/2007 12/31/2007 01/15/2008
14.68K 09/26/2007 08/23/2007 09/28/2007 10/15/2007
14.68K 06/27/2007 05/17/2007 06/29/2007 07/13/2007
14.68K 03/28/2007 03/22/2007 03/30/2007 04/13/2007
14.68K 12/27/2006 12/04/2006 12/29/2006 01/15/2007
13.58K 09/27/2006 08/11/2006 09/30/2006 10/13/2006
13.58K 06/28/2006 05/17/2006 06/30/2006 07/14/2006
13.58K 03/29/2006 03/14/2006 03/31/2006 04/14/2006
13.58K 12/28/2005 11/08/2005 12/30/2005 01/13/2006
12.66K 09/28/2005 09/09/2005 09/30/2005 10/14/2005
12.66K 06/28/2005 05/20/2005 06/30/2005 07/15/2005
253.27K 03/29/2005 02/04/2005 03/31/2005 04/15/2005
253.27K 12/29/2004 12/07/2004 12/31/2004 01/14/2005
234.92K 09/28/2004 09/24/2004 09/30/2004 10/15/2004
234.92K 06/28/2004 05/14/2004 06/30/2004 07/15/2004
234.92K 03/29/2004 02/26/2004 03/31/2004 04/15/2004
234.92K 12/29/2003 12/09/2003 12/31/2003 01/15/2004
212.89K 09/26/2003 09/18/2003 09/30/2003 10/15/2003
212.89K 06/30/2003 06/25/2003 07/02/2003 07/15/2003
212.89K 03/27/2003 02/11/2003 03/31/2003 04/15/2003
190.87K 12/27/2002 12/12/2002 12/31/2002 02/03/2003
954.35K 09/26/2002 09/18/2002 09/30/2002 10/15/2002
954.35K 06/26/2002 05/17/2002 06/28/2002 07/15/2002
954.35K 03/26/2002 03/21/2002 03/29/2002 04/15/2002
880.94K 12/27/2001 12/14/2001 12/31/2001 01/15/2002
880.94K 09/26/2001 09/19/2001 09/28/2001 10/12/2001
880.94K 06/27/2001 06/04/2001 06/29/2001 07/13/2001
880.94K 03/28/2001 03/08/2001 03/30/2001 04/13/2001
880.94K 12/27/2000 12/13/2000 12/29/2000 01/15/2001
880.94K 09/27/2000 09/11/2000 09/29/2000 10/13/2000
880.94K 06/28/2000 05/19/2000 06/30/2000 07/15/2000
880.94K 03/29/2000 02/29/2000 03/31/2000 04/17/2000
880.94K 12/29/1999 12/13/1999 12/31/1999 01/15/2000
880.94K 09/28/1999 09/17/1999 09/30/1999 10/15/1999
880.94K 06/28/1999 06/17/1999 06/30/1999 07/15/1999
880.94K 03/29/1999 02/04/1999 03/31/1999 04/15/1999
1.47M 10/29/1997 09/22/1997 10/31/1997 12/15/1997
1.47M 06/26/1997 06/17/1997 06/30/1997 07/31/1997
2.64M 03/25/1997 03/18/1997 03/28/1997 04/30/1997
2.64M 11/22/1996 11/14/1996 11/26/1996 01/31/1997
2.64M 08/22/1996 08/13/1996 08/26/1996 10/11/1996
2.64M 05/28/1996 05/20/1996 05/30/1996 06/28/1996
2.64M 02/22/1996 02/13/1996 02/26/1996 03/13/1996
2.64M 11/16/1995 11/09/1995 11/20/1995 12/08/1995
2.64M 08/17/1995 08/11/1995 08/21/1995 08/31/1995
2.64M 05/16/1995 05/16/1995 05/22/1995 05/31/1995
2.64M 02/13/1995 02/13/1995 02/17/1995 02/28/1995
2.64M 11/16/1994 11/16/1994 11/22/1994 11/30/1994
2.64M 08/12/1994 08/12/1994 08/18/1994 08/29/1994
2.64M 05/16/1994 05/16/1994 05/20/1994 05/26/1994
2.64M 02/09/1994 02/09/1994 02/15/1994 02/25/1994
2.64M 11/02/1993 11/02/1993 11/08/1993 11/19/1993
807.53K 07/06/1993 07/06/1993 07/12/1993 07/23/1993